Literature DB >> 8023951

Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells.

P Hu1, H Ischiropoulos, J S Beckman, S Matalon.   

Abstract

Active sodium (Na+) transport by alveolar type II (ATII) cells plays an important role in limiting the volume of alveolar fluid. Reactive oxygen and nitrogen species, released in the epithelial lining fluid by activated inflammatory cells or present in inspired gases, may damage Na+ transporters and decrease fluid reabsorption. To test this hypothesis we exposed ATII cells to xanthine and xanthine oxidase (1 or 10 mU/ml), or to boluses of peroxynitrite (0.1-1 mM final concentration) for 15 min and measured 1) cellular oxygen consumption (VO2); 2) amiloride-inhibitable 22Na+ uptake, as an index of Na+ movement through apically located Na+ channels; and 3) ouabain-sensitive 86Rb+ uptake, as an index of the activity of the basolaterally located Na(+)-K(+)-ATPase. After exposure of ATII cells to 0.5 or 1 mM peroxynitrite, amiloride-inhibitable 22Na+ uptake decreased to 68 +/- 7 and 56 +/- 11 of their control values, respectively (mean +/- SE; n > or = 6). Exposure to 0.5 mM peroxynitrite decreased ATII cell VO2 from 76 +/- 6 to 25 +/- 5 microM.h-1 x 10(6) cells-1 (mean +/- SE; n = 5). Cell viability and ouabain-sensitive 86Rb+ uptake remained at control levels for either peroxynitrite concentration. Exposure of ATII cells to 10 mU/ml xanthine oxidase decreased their VO2 from 94 +/- 8 to 63 +/- 6 (mean +/- SE; n = 5), but did not alter amiloride-inhibitable 22Na+ uptake. These findings indicate that physiological concentrations of peroxynitrite, but not of reactive oxygen species, decrease ATII cell Na+ transport by damaging apically located amiloride-sensitive Na+ channels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023951     DOI: 10.1152/ajplung.1994.266.6.L628

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

Review 2.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

3.  Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection.

Authors:  Judy M Hickman-Davis; Carmel McNicholas-Bevensee; Ian C Davis; He-Ping Ma; Glenda C Davis; Charles A Bosworth; Sadis Matalon
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

Review 4.  Inhaled vasodilator therapy in acute lung injury: first, do NO harm?

Authors:  S J Brett; T W Evans
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

5.  Counterprotective effect of erythrocytes in experimental bacterial peritonitis is due to scavenging of nitric oxide and reactive oxygen intermediates.

Authors:  Y M Kim; S J Hong; T R Billiar; R L Simmons
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 6.  Role of oxidative stress and nitric oxide in atherothrombosis.

Authors:  Edith Lubos; Diane E Handy; Joseph Loscalzo
Journal:  Front Biosci       Date:  2008-05-01

7.  Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia.

Authors:  L M Carlsson; J Jonsson; T Edlund; S L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  Increased expression and activity of sodium channels in alveolar type II cells of hyperoxic rats.

Authors:  G Yue; W J Russell; D J Benos; R M Jackson; M A Olman; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

9.  Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.

Authors:  I Y Haddad; G Pataki; P Hu; C Galliani; J S Beckman; S Matalon
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice.

Authors:  D Torres-Dueñas; M R N Celes; A Freitas; J C Alves-Filho; F Spiller; D Dal-Secco; V F Dalto; M A Rossi; S H Ferreira; F Q Cunha
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.